Anton Hospach Selected Research

Anton Hospach Research Topics

9	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 11/2021 - 11/2015
3	Infections 04/2021 - 01/2020
3	Uveitis 10/2020 - 11/2016
2	Arthritis (Polyarthritis) 01/2023 - 11/2015
2	Psoriatic Arthritis 01/2023 - 11/2015
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2020 - 11/2015
2	Neoplasms (Cancer) 10/2020 - 11/2016
2	Cytopenia 01/2020 - 01/2020
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2024
1	Dermatomyositis (Dermatopolymyositis) 02/2022
1	Myositis (Idiopathic Inflammatory Myopathies) 02/2022
1	Muscle Weakness 02/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Proteinuria 01/2022
1	Injection Site Reaction 11/2021
1	Necrosis 04/2021
1	Opportunistic Infections (Opportunistic Infection) 04/2021
1	Communicable Diseases (Infectious Diseases) 04/2021
1	Herpes Zoster 10/2020
1	Macrophage Activation Syndrome 01/2020
1	Fever (Fevers) 01/2018

6	Etanercept (Enbrel)FDA Link 11/2021 - 11/2016
4	tocilizumab (atlizumab)FDA Link 01/2020 - 11/2016
3	Interleukin-1 (Interleukin 1)IBA 04/2021 - 11/2017
2	Methotrexate (Mexate)FDA LinkGeneric 04/2024 - 11/2016
2	Interleukin-6 (Interleukin 6)IBA 04/2021 - 01/2020
1	Antirheumatic Agents (DMARD)IBA 04/2024
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2023
1	AutoantibodiesIBA 02/2022
1	Creatine Kinase (Creatine Phosphokinase)IBA 02/2022
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022
1	Biosimilar PharmaceuticalsIBA 11/2021
1	Interleukin-6 InhibitorsIBA 04/2021
1	Abatacept (Orencia)FDA Link 04/2021
1	InterleukinsIBA 04/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2021
1	SteroidsIBA 01/2020
1	Transaminases (Aminotransferases)IBA 01/2020
1	canakinumab FDA Link 01/2020
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2020
1	hydroxide ionIBA 12/2018
1	Vitamin D FDA LinkGeneric 12/2018
1	C-Reactive ProteinIBA 01/2018
1	GlucocorticoidsIBA 01/2018
1	Adalimumab (Humira)FDA Link 11/2016
1	Rheumatoid FactorIBA 11/2015